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Do Psychosocial Interventions Improve
Quality of Life and Wellbeing in Adults
with Neuromuscular Disorders? A
Systematic Review and Narrative Synthesis
Elaine Walkleta,b,∗, Kate Museb, Jane Meyricka and Tim Mossa
aHealth and Social Sciences Department, University of the West of England, Bristol, UK
bPsychology Department, University of Worcester, Worcester, UK
Abstract. Quality of life and well-being are frequently restricted in adults with neuromuscular disorders. As such, identifica-
tion of appropriate interventions is imperative. The objective of this paper was to systematically review and critically appraise
quantitative studies (RCTs, controlled trials and cohort studies) of psychosocial interventions designed to improve quality of
life and well-being in adults with neuromuscular disorders. A systematic review of the published and unpublished literature
was conducted. Studies meeting inclusion criteria were appraised using a validated quality assessment tool and results pre-
sented in a narrative synthesis. Out of 3,136 studies identified, ten studies met criteria for inclusion within the review. Included
studies comprised a range of interventions including: cognitive behavioural therapy, dignity therapy, hypnosis, expressive
disclosure, gratitude lists, group psychoeducation and psychologically informed rehabilitation. Five of the interventions were
for patients with Amyotrophic Lateral Sclerosis (ALS). The remainder were for patients with post-polio syndrome, muscular
dystrophies and mixed disorders, such as Charcot-Marie-Tooth disease, myasthenia gravis and myotonic dystrophy. Across
varied interventions and neuromuscular disorders, seven studies reported a short-term beneficial effect of intervention on
quality of life and well-being. Whilst such findings are encouraging, widespread issues with the methodological quality of
these studies significantly compromised the results. There is no strong evidence that psychosocial interventions improve
quality of life and well-being in adults with neuromuscular disorders, due to a paucity of high quality research in this field.
Multi-site, randomised controlled trials with active controls, standardised outcome measurement and longer term follow-ups
are urgently required.
Keywords: Neuromuscular diseases, adult, quality of life, psychology, review
INTRODUCTION
Neuromuscular disorders have a high symptom
burden and are frequently associated with many
∗Correspondence to: Elaine Walklet, Department of Psychol-
ogy, University of Worcester, Henwick Grove, WR2 6AJ, UK.
Tel.: +44 01905 542420; E-mail: e.walklet@worc.ac.uk.
adverse psychosocial outcomes, particularly reduced
quality of life and well-being [1, 2]. The World Health
Organisation (WHO) defines quality of life as the
way in which an individual perceives their individ-
ual position in life with respect to their goals and
standards and suggests this broad construct can be
affected by the individual’s physical health, psy-
chological health, independence, and relationships
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with others and the environment [3]. Health-related
quality of life (HRQoL) is one aspect of this multi-
faceted concept and refers to the physical, social and
psychological domains of health, influenced by an
individual’s beliefs, expectations and experiences [4].
Despite clinical variation between slowly progres-
sive (e.g. Facioscapulohumeral Muscular Dystrophy)
and rapidly progressive (e.g. Amyotrophic Lateral
Sclerosis) neuromuscular conditions, perceptions of
self-reported quality of life and HRQoL are com-
parably low in individuals with different types of
neuromuscular disorders [5, 6].
Recently, researchers have noted that quality of
life assessments typically focus on deficits in func-
tioning and have argued that an absence of deficits
is not synonymous with positive functioning. Con-
sequently, it has been suggested that well-being, an
asset approach to functioning assessing positive psy-
chological variables, should also be considered as an
important outcome in chronic illness [7, 8]. Indeed
recent definitions of health now emphasise positive
psychological factors, namely the ability to adapt
and self-manage [9]. Arguably a difficult construct to
define, one key conceptualisation of well-being, sub-
jective well-being, has been described as ‘an umbrella
term for different valuations that people make regard-
ing their lives, the events happening to them, their
bodies and minds, and the circumstances in which
they live’ [10]. In contrast, psychological well-being
encompasses concepts such as personal growth, mas-
tery, resilience and acceptance [11]. Limited available
research suggests that well-being may be important in
neuromuscular disorders. For example, research has
found adults with amyotrophic lateral sclerosis and
high well-being have a risk of mortality seven times
lower than those experiencing distress, irrespective
of disease severity and length of illness [12].
Given the potential importance of both quality of
life and wellbeing in the experience of neuromuscu-
lar disease, it is essential that effective interventions
are identified. Indeed both patients with neuromuscu-
lar disorders and researchers have argued this should
be a research priority [13, 14]. Understanding fac-
tors which affect quality of life and well-being is
important for the design and delivery of effective
interventions. Critically, research has consistently
found that psychosocial factors are better predic-
tors of quality of life than physical impairment in
adults with neuromuscular disorders [15–17]. Such
findings indicate that interventions targeting psy-
chosocial factors could therefore improve quality of
life and well-being in this group.
Psychosocial interventions are interventions which
target psychological and/or social factors, as opposed
to biological factors. These include, for example, all
psychological therapies (e.g. cognitive behavioural
therapy), psychoeducation and peer support. Such
interventions can be delivered in individual and
group formats [18]. Systematic reviews and meta-
analyses indicate these interventions can improve
quality of life and well-being in adults with
long-term conditions such as cancer and diabetes
[19–21].
To date, no systematic review has considered
the effectiveness of psychosocial interventions for
improving quality of life and well-being across neu-
romuscular disorders. This is problematic as the
effectiveness of these interventions and methodolog-
ical quality of the research undertaken to assess
effectiveness is largely unknown. Thus far, one pub-
lished systematic review has assessed psychotherapy
and pharmacotherapy interventions for improving
well-being and reducing distress in ALS. Based on
the results of four included studies, the authors con-
cluded that there was insufficient evidence to make
recommendations for psychotherapy [22]. It should
be noted, however, that the focus of this review on
one aspect of psychosocial interventions (psychother-
apy) and a single neuromuscular condition limits
the wider applicability of these findings. The impor-
tance of reviewing evidence across neuromuscular
disorders for non-pharmacological interventions has
previously been highlighted but, so far, has been lim-
ited to exercise and physical therapy interventions
[23]. A systematic review on the effectiveness of psy-
chosocial interventions for improving quality of life
and well-being in adults with neuromuscular condi-
tions is now required.
Hence, this review sought to address gaps in
the evidence and investigate the effectiveness of
psychosocial interventions across neuromuscular dis-
orders, with a view to making recommendations
about effective interventions and developments for
future research. The aim was to systematically review
the literature on the impact of psychosocial interven-
tions on quality of life and wellbeing in adults with
neuromuscular disorders.
METHOD
Search strategy
A systematic search of published and unpub-
lished literature was conducted between June and
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October 2015. This included the following online
databases: PsycInfo (1909-present), PsycArticles
(1909-present), Medline (1964-present), CINAHL
(1984-present), AMED (1988-present), Web of Sci-
ence (1900 - present), and the Cochrane Register of
Controlled Clinical Trials (CENTRAL). Databases
were searched on 9th June 2015 using a Boolean
search devised in PsycInfo and adapted to other
databases. Due to the small number of studies identi-
fied in initial scoping searches, a broad set of free-text
search terms were devised around the key concepts of
neuromuscular disorders, psychosocial interventions
and quality of life/well-being (See Supplementary
Material for full search strategy).
A similar search strategy was employed to search
COS Conference Papers Index and Open Grey. Hand
searching of the Cochrane Neuromuscular Disease
Group (all publications) was also conducted. To
broaden the search, identified experts in the field and
neuromuscular disease charities were also contacted.
Citation tracking (using Google Scholar) and hand
searching of reference lists were carried out for all
included studies.
Inclusion/Exclusion criteria
To be included in the current review, identified
studies had to meet the following criteria:
1. Study design either randomised controlled trial
(RCT), controlled trial or cohort study.
2. Participants all adults (18+) with a diagnosis of
a neuromuscular disorder. Neuromuscular disor-
ders were defined as disorders of the motor unit,
with common examples including motor neu-
ron disorders (e.g. Amyotrophic Lateral Sclerosis
[ALS]), nerve junction disorders (e.g. Myasthe-
nia Gravis), muscle disorders (e.g. Duchenne
Muscular Dystrophy) and peripheral nerve dis-
orders (e.g. Charcot-Marie-Tooth disease) [24].
In accordance with a previous systematic review,
studies of patients with neuromuscular symp-
toms not attributed to a specific neuromuscular
disorder, and studies of patients with diabetic
neuropathy, entrapment neuropathy and radicu-
lopathies were not included [23]. Where studies
contained mixed samples, 75% NMD diagnoses
was deemed acceptable.
3. Participants received a psychosocial interven-
tion. Psychosocial interventions were defined as
interventions targeting psychological and social
factors, as opposed to biological or medical.
Common examples include all psychotherapies
(such as cognitive behavioural therapy [CBT]),
psychoeducation, peer support and expressive
disclosure). In accordance with previous reviews,
multi-faceted interventions including a biological
component but with a clear psychosocial empha-
sis were included [18].
4. Quality of life and/or well-being of patients
assessed as quantitative outcome measure(s).
Additional patient specific outcomes (e.g. fatigue,
coping etc.) and outcomes for other participant
groups (e.g. caregivers) were beyond the scope of
this review and, as such, not included.
5. Publication in English language.
Study selection
To determine eligibility of identified studies, pri-
mary screening of titles and abstracts was conducted
independently by two of the authors (EW & KM).
Articles that seemed to fulfil the inclusion criteria
were subsequently obtained in full-text and subject
to independent secondary screening by both authors.
To facilitate secondary screening, a data extraction
form was developed and used to assess eligibility of
articles obtained in full-text. In accordance with cur-
rent guidelines, inclusion of studies was determined
by agreement between both reviewers [25].
Assessment of quality
The Effective Public Health Practice Project
(EPHPP) Quality Assessment Tool for Quantitative
Studies [26] was utilised to assess methodologi-
cal quality of all included studies1. The EHPP was
deemed more appropriate for the current review than
the Cochrane Risk of Bias Tool [27, 28] because the
EHPP was developed for use with all quantitative
designs (not just RCTs) and has been found to have
greater inter-rater agreement [29]. The EPHPP tool
allows reviewers to derive a global rating of quality
from the following components: selection bias, study
design, confounders, blinding and withdrawals and
drop-outs. Quality of included studies was indepen-
dently assessed by two of the authors (EW & KM),
with disagreement resolved via discussion.
1See http://www.ephpp.ca/PDF/Quality%20Assessment%20
Tool 2010 2.pdf and http://www.ephpp.ca/PDF/QADictionary
dec2009.pdf for Quality Assessment Tool.
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Study synthesis
In accordance with relevant guidelines, a nar-
rative synthesis was deemed the most appropriate
method of analysis due to substantial heterogeneity
between included studies (e.g. design and outcome
measures) which meant that meta-analysis was pre-
cluded [27, 30, 31]. A narrative synthesis should
involve a preliminary synthesis of findings, an explo-
ration of relationships in the data, an assessment of
quality of the evidence and, if appropriate and fea-
sible, the development of a theoretical model about
the way in which an intervention works. Accordingly,
quality appraisal, tabulation of the data, grouping by
intervention type and study quality and analysis of
variables influencing effectiveness were used as tools
to facilitate the current narrative synthesis [30].
RESULTS
Included studies
After removal of duplicates, a total of 3,136 stud-
ies were extracted from online databases and other
sources. Following primary screening, 3,117 studies
were excluded as ineligible, with common reasons
for exclusion comprising: not an intervention study,
not an appropriate sample (condition or age), not a
relevant outcome and not an empirical study. Thus,
nineteen articles were retrieved as full-text for sec-
ondary screening, of which ten articles were included
within the review (see Fig. 1 for study selection flow
diagram).
Study characteristics
The vast majority of included studies (8 of the 10)
were published in the last four years. Of the included
studies, three were randomised controlled trials
(RCT) [32–34], four were cohort analytic trials (CAT)
[35–38] and three were cohort (pre-post) designs
[39–41] (see Table 1 for intervention details and sum-
mary outcomes). Most studies were small, with the
total number of participants ranging from eight –
80 (M = 39.1). Participant demographics were varied.
Samples consisted of between 32% and 74% males.
Half of the interventions were for patients with ALS
[32, 33, 38, 40, 41]. One study was for patients with
post-polio syndrome [34], one study was for patients
with mixed muscular dystrophies (e.g. facioscapuolo-
humeral muscular dystrophy, becker dystrophy and
limb-girdle dystrophy etc.) [36] and the remaining
three studies were for patients with mixed types of
neuromuscular conditions (e.g. Charcot-Marie-Tooth
disease, myasthenia gravis, post-polio syndrome and
myotonic dystrophy etc.) (please see Table 1 for
full list of conditions and sample sizes) [35, 37,
39]. Interventions were varied and included cogni-
tive behavioural therapy [33, 34, 37], hypnosis [38,
40], dignity therapy [41], expressive disclosure[32],
gratitude lists [35], comprehensive rehabilitation [36]
and a psychoeducational fatigue management group
[39]. The length of interventions ranged from one
hour to 10 days, delivered over periods of between
one week and 18 months. Six of the interventions
were home-based [32, 35, 37, 38, 40, 41] and four
were delivered in clinic settings [33, 34, 36, 39]. The
majority of interventions were face to face [33, 34,
36, 38–41], with two delivered remotely via written
instructions [32, 35], and one delivered online [37].
Outcomes pertaining to quality of life and well-being
were measured in different ways across studies. Only
four studies included a six month follow-up to investi-
gate longer term effects of interventions [32–34, 38].
Quality appraisal
Using the EPHPP Quality Assessment Tool for
Quantitative Studies [26], three RCTs were appraised
as moderate in quality and the remainder were
appraised as weak (see Table 2 for quality appraisal
ratings). Amongst the three moderate studies, small
sample sizes, insufficient blinding, selective outcome
reporting and use of a non-active control were prob-
lematic. In one study, a strong design was hampered
by slow recruitment and retention resulting in the trial
being stopped prematurely [33]. Similar issues were
identified in the seven studies appraised as weak. Of
these studies, three used a non-equivalent control and
three did not utilise any form of control. Most weak
studies recruited participants from a single site or
support group and thus are likely to be affected by
selection bias. In many weak studies it was unclear
whether co-intervention/contamination had occurred
as this information was not clearly reported. Across
all studies, blinding was particularly weak, with only
two studies using blinded outcome assessors [33,
34]. Overall, fidelity to the intervention was not ade-
quately assessed. In contrast, data collection (e.g. use
of validated scales etc.) was generally strong.
Study findings: Effectiveness of interventions
Due to the heterogeneous nature of included stud-
ies, a meta-analysis was precluded. Instead, studies
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Fig. 1. Flow diagram of study selection process.
were grouped according to intervention type, out-
come measurement and moderators of effectiveness
as these groupings were deemed most pertinent to
intervention effectiveness.
Psychotherapy interventions
Six studies investigated psychotherapy interven-
tions, the most frequent of which was Cognitive
Behavioural Therapy (CBT). One moderate quality
RCT investigated CBT tailored to the management
of fatigue in individuals with post-polio syndrome
and self-reported severe fatigue [34]. The study
found no difference in HRQoL between partici-
pants randomised to CBT and a usual care control
group immediately post-intervention and at the three
and six month follow-up. The authors reported a
slightly greater occurrence of co-interventions (e.g.
medication, assistive devices etc.) in the control
group, which could have potentially confounded
the results. However, neither the CBT or control
group showed any improvement over time. The
authors suggest that as post-polio syndrome has an
early onset, acceptance of fatigue may develop over
time, thus reducing the effectiveness of intervention
[34].
In contrast, another moderate quality RCT inves-
tigated CBT based on a stress-coping model for
patients with ALS and their partners [33]. The study
found that, compared to a non-active control, inter-
vention patients’ mental quality of life deteriorated
less over time between baseline and six month follow-
up. However, this effect was only found in one
of the two measures used. It should also be noted
that the very small sample size in this study (total
n = 15) means that the statistical tests utilised were not
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Table 2
Quality appraisal of all included studies
Study Selection Study Confounds Blinding Data Withdrawals/ Global Additional
Bias Design Collection Dropouts rating Notes
[36] Moderate Moderate Weak Weak Strong Strong Weak A small number of the control group
were also receiving rehabilitation. No
intervention protocol provided.
Quality and consistency of
intervention not measured.
[41] Weak Moderate N/A Weak Strong Moderate Weak No control group. Detailed protocol for
intervention provided and sessions
recorded but not rated for quality and
adherence.
[32] Moderate Strong Strong Weak Moderate Strong Moderate Selective outcome reporting.
Standardised instructions provided but
adherence to intervention not
measured.
[39] Weak Moderate N/A Weak Strong Strong Weak No control group. Content of
intervention described but no method
of checking quality and adherence.
[35] Weak Weak Weak Weak Weak Weak Weak Standardised instructions provided.
Manipulation check confirmed
gratitude condition elicited greater
expressions of gratitude than control.
Mean outcomes across intervention
period calculated for analyses.
[38] Weak Moderate Strong Weak Strong Strong Weak Small sample. Intervention protocol but
no method of checking quality and
adherence. 5 intervention participants
were also receiving
psychopharmacology
[34] Weak Strong Strong Moderate Strong Moderate Moderate Small sample. Standardised CBT
modules utilised and selected via
criteria. Quality and adherence not
assessed. Co-interventions received in
control and treatment groups.
[37] Weak Moderate Weak Weak Strong Weak Weak Participants assigned to control group if
they did not have access to a
computer/webcam. Detailed protocol
for intervention provided but no
method of checking quality and
adherence. Significant baseline
differences in quality of life not
controlled in analysis.
[40] Weak Weak N/A Weak Moderate Strong Weak No control group. Small sample size.
Intervention protocol but no method of
checking quality and adherence
described.
[33] Weak Strong Strong Moderate Strong Strong Moderate Small sample. Standardised CBT module
utilised but no method of checking
quality and adherence. Trial stopped
prematurely due to slow recruitment
and missing data.
Note: Global quality ratings were calculated from component ratings in accordance with criteria specified in the EPHPP tool. Global rating
‘weak’ = 2 + weak component ratings; global quality rating ‘moderate’ = 1 weak component rating; global quality rating ‘strong’ = no weak
component ratings. See http://www.ephpp.ca/PDF/Quality%20Assessment%20Tool 2010 2.pdf.
adequately powered [33]. The contribution of these
findings to the evidence base is therefore question-
able.
Additionally, a CAT appraised as weak in qual-
ity investigated the efficacy of a CBT-based online
intervention delivered via video conference [37]. The
intervention was tailored to neuromuscular disorders
and involved psychoeducation, managing emotional
reactions, cognitive restructuring, problem solving
and relaxation exercises for groups of patients with
mixed neuromuscular disorders. Across the three dif-
ferent measures of HRQoL, the authors reported the
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intervention group significantly improved between
baseline and follow-up (4 ½ months later) on over-
all HRQoL and most subscales. It should be noted,
however, that the intervention group had significantly
lower levels of baseline HRQoL than the control
group and at follow-up the two groups were com-
parable. As appropriate statistical analyses were not
conducted to calculate the group × time interaction or
control for baseline differences, the results may sim-
ply reflect regression to the mean in the intervention
group.
Two linked, weak quality studies investigated
the effect of a hypnosis intervention on quality of
life and psychological well-being in patients with
ALS. The first was a small pilot cohort study
which assessed the impact of four sessions of Psy-
chologist delivered hypnosis around issues such as
illness acceptance, resilience and physical symp-
tom control, in addition to self-hypnosis training
[40]. In the absence of a control group, the authors
reported significant improvements in one measure
of HRQoL and subscales negative emotion and
religiousness/spirituality. However, only eight partic-
ipants took part in the study and therefore statistical
tests were not adequately powered. Moreover, effects
were not replicated in the second measure of HRQoL
utilised in the study. Generalisability of the findings is
therefore limited. This intervention was subsequently
extended to a brief psychodynamic-based hypnosis
intervention with four sessions on topics labelled
safe place, awareness, life chain and perceptive [38].
Assessing the impact on HRQoL for 15 interven-
tion participants and 15 matched controls, the authors
reported a small effect of treatment on HRQoL imme-
diately post intervention and at three months, with
scores reverting towards baseline levels at six months.
It should be noted however, that one third of the inter-
vention group participants were receiving a low dose
antidepressant or anxiolytic which could potentially
confound the results.
The final weak cohort study assessed the impact
of dignity therapy on HRQoL and spiritual well-
being in patients with ALS and their caregivers [41].
Dignity therapy involves an in-depth interview with
patients on their accomplishments in life and things
they would like to pass on to loved ones which is
later transcribed to create a permanent record for the
individual and their family [41]. In a pre-post design
the authors reported no significant impact on HRQoL
or spiritual well-being one week post-intervention.
Results are difficult to interpret due to the absence of
a control. Moreover, the absence of an effect could
potentially be influenced by the short follow-up time
and brief measure used to assess HRQoL which may
not be sensitive to change.
In summary, evidence for the effectiveness of psy-
chotherapy interventions was mixed, with some types
of psychotherapy found to be beneficial for qual-
ity of life and well-being (e.g. CBT and hypnosis)
and some types found to be ineffective (e.g. CBT
for fatigue and dignity therapy). Study quality was
generally higher for CBT-related interventions than
other forms of psychotherapy, however all studies had
considerable methodological limitations.
Private expressive communication
Two studies examined the effects of private expres-
sive communication interventions on well-being.
One moderate quality RCT investigated expressive
disclosure in patients with ALS [32]. Participants
randomised to the intervention either wrote or audio
recorded themselves speaking about their deepest
thoughts in relation to their condition for three days
in a one week period. Control participants completed
outcome measures only. The authors reported a sig-
nificant increase in psychological well-being from
pre-post intervention in the expressive disclosure
group, which was maintained at three months. In
contrast, the control group experienced deterioration
in psychological well-being from pre-post interven-
tion which was also maintained at three months. Both
groups reverted to near baseline levels at six months
suggesting the effectiveness of the intervention was
not maintained beyond three months. Furthermore,
the use of a non-active control and selective out-
come reporting (individual measures used to create
a composite ‘psychological wellbeing’ score are not
reported) limit the generalisability of findings.
An expressive communication intervention with a
different emphasis was utilised by one CAT appraised
as weak in quality [35]. In this gratitude intervention,
participants with slowly progressive neuromuscular
conditions (Charcot-Marie-Tooth disease, post-polio
syndrome & facioscapuolohumeral dystrophy) were
asked to write down five things they were grateful for
and complete experience ratings daily for 21 days.
Control participants completed the experience ratings
but were not asked to write gratitude lists. The study
found the intervention group had significantly higher
subjective well-being than the control group across
the 21 day study period. It should be noted, however,
that a three-item measure was developed by the author
to assess subjective well-being and the reliability and
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validity of this measure are unknown. This study also
assessed observer reports of well-being, with care-
givers/spouses asked to complete measures of life
satisfaction and positive and negative affect from the
patient’s perspective at the end of the intervention.
The authors reported that life satisfaction and positive
affect were rated significantly higher for intervention
group patients compared with ratings for patients in
the control group; no differences were reported for
negative affect. The absence of any follow-up mea-
sures for this intervention beyond the 21 day study
period mean it is not possible to establish whether
effects were maintained.
In summary, there was some evidence for the effec-
tiveness of expressive disclosure and gratitude lists
in improving well-being, albeit in the short-term.
As with psychotherapy interventions, the quality of
evidence for private expressive communication inter-
ventions was limited.
Group psychoeducation/Comprehensive
rehabilitation
Two weak quality studies assessed group-based
psychosocial interventions delivered in clinic set-
tings. One cohort study assessed an educational
fatigue management intervention for patients with
mixed slowly progressive neuromuscular conditions
or multiple sclerosis [39]. Between baseline and
three months post intervention, significant improve-
ments were found in role-physical, mental health and
general health perceptions subscales of the HRQoL
measure SF-36 [42]. The absence of a control group
makes the results difficult to interpret. The sec-
ond study did utilise a control group (usual care)
and found no significant change in HRQoL, psy-
chological well-being or mood following a 10 day
comprehensive rehabilitation programme for adults
with muscular dystrophy [36]. It should be noted that
a small number of the control group were also receiv-
ing rehabilitation which was not controlled for in the
analyses.
In summary, whilst there was weak evidence for the
effectiveness of group-based psychoeducation and
the ineffectiveness of comprehensive rehabilitation,
the absence of appropriate controls within studies
inhibited meaningful interpretation of findings.
Study findings: Assessment of quality of life and
well-being
Quality of life and well-being were defined and
assessed differently across all included studies,
thereby complicating interpretation of findings (see
Table 1). In one study, psychological well-being
was considered a multi-faceted concept incorporating
HRQoL [32]. Conversely, in another study, quality
of life was defined and assessed as a multi-faceted
concept incorporating psychological well-being [36].
The majority of studies on ALS utilised one of sev-
eral ALS specific measures of HRQoL. Both studies
utilising the ALSAQ-5 [43] reported no significant
effects, despite effects found in other similar mea-
sures in one of these studies [40, 41]. This suggests
that different measures of HRQoL may be measuring
different constructs. Amongst other neuromuscular
conditions, the SF-36 [42], and SIP [44] were most
commonly used to assess generic HRQoL. The two
studies utilising a specific validated measure of well-
being (as opposed to a composite measure or author
developed scale) did not report any beneficial effects
[36, 41]. Overall, outcome measurement was prob-
lematic and lacked a consistent approach across
studies.
Study findings: Factors influencing effectiveness
Only two studies investigated factors which may
have influenced effectiveness of the intervention
on quality of life and/or well-being. Averill and
colleagues [32] reported that higher ambivalence
over expressing emotion was associated with greater
increases in psychological-wellbeing three months
after expressive disclosure. Boosman and colleagues
[39] reported greater improvements in HRQoL
following a fatigue management intervention in par-
ticipants who were male, individuals with lower
education levels and those with lower baseline self-
efficacy.
A set of criteria were derived from interventions
in the included studies. Subsequently, components
of each intervention were extracted and compared to
allow for the identification of variables influencing
effectiveness (see Table 3). No clear findings emerged
from this analysis. Further research examining poten-
tial moderating factors is, therefore, required.
DISCUSSION
Key findings
This systematic review sought to synthesise the
available evidence for the effectiveness of psychoso-
cial interventions on quality of life and wellbeing in
adults with neuromuscular disorders. Furthermore, it
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Table 3
A comparison of intervention factors within included studies
Study Theoretical Protocol/ Delivered by Provides Targets Targets Targets Targets Facilitates
basis Manual Psychologist psycho-education emotional relaxation cognitions behaviours social
specified expression support
[34]     X X   
[32] X  X X  X X X X
[33]      X   
[36] X X X  X X X  
[35] X  X X  X X X X
[38]    X X  X X X
[37]         
[41] X   X  X X X X
[39] X  X X X X  
[40] X   X X  X X X
= No significant effects of intervention on quality of life and/or well-being. Note: Intervention factors were derived from variables within
included studies.
sought to critically appraise the methodological qual-
ity of this evidence. Despite calls for research on
psychosocial interventions in this patient group [14,
45], only a small number of studies have been con-
ducted. Of the 10 included studies, seven reported a
beneficial effect of psychosocial interventions across
different neuromuscular disorders. Overall, there is
mixed and contradictory evidence for the effective-
ness of CBT in improving HRQoL and mental quality
of life, with moderate evidence of its ineffective-
ness in severely fatigued participants [33, 34, 37].
It should be noted that CBT is the only intervention
where a beneficial effect was found to be maintained
at six months post intervention [33]; however, this
may reflect a paucity of longer-term follow-up data
in other studies. In the short-term, there was mod-
erate evidence for emotional disclosure improving
psychological well-being [32], weak evidence for
gratitude lists improving subjective well-being [35],
and weak evidence for hypnosis [38, 40] and a fatigue
psychoeducational group [39] improving HRQoL. In
contrast, there was weak evidence to suggest that dig-
nity therapy does not improve HRQoL and spiritual
well-being [41] and that comprehensive rehabilita-
tion does not improve global quality of life [36].
In summary, there is currently insufficient evidence
to support the use of psychosocial interventions to
improve quality of life and well-being in adults with
neuromuscular disorders.
The majority of included studies were rated as
weak in quality, with only three rated as moderate
and none as strong. Across studies, factors relating to
selection bias, study design and blinding were partic-
ularly problematic. The majority of studies recruited
a small number of participants, often from a single
source. Whilst this may reflect the rarity of neuro-
muscular conditions and the challenges they pose to
engagement in activities [24], the risk of biased sam-
pling limits generalisability of findings. With respect
to study design, none of the included studies utilised
an active control and three studies included no form
of control at all. Thus, positive findings could be
due to non-specific treatment effects. Importantly, as
many studies did not assess long-term outcomes of
interventions, inferences regarding long-term effects
cannot be made. In most studies there was no blind-
ing, with participants and outcome assessors fully
aware of the research question and group alloca-
tions. Furthermore, consistency of the intervention
was rarely assessed beyond the development of treat-
ment protocols. In the context of these numerous risks
of bias, caution must be exercised in interpretation of
findings.
Further challenges to useful synthesis within this
systematic review arose from the widespread het-
erogeneity amongst included studies. In particular,
contrasting definitions and assessment methods for
quality of life and well-being impeded meaningful
comparison across studies. It is possible that this
is reflective of confusion surrounding these terms
within the wider literature and the field of neuro-
muscular disease [46, 47]. HRQoL was the most
commonly assessed outcome, however many differ-
ent measures were utilised. Across all outcomes, a
diverse group of measures were employed includ-
ing both disorder specific and generalised measures
and both single measures and multiple/composite
measures. Of further concern, some studies reported
contradictory findings when different measures were
utilised to assess the same construct within an individ-
ual study [33, 40], thereby providing evidence against
the comparability of outcome measures. Thus, the
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extent to which quality of life and well-being were
validly and reliably assessed is cause for concern.
Study heterogeneity also precluded the develop-
ment of a theoretical model about the way in which
the included interventions work. Identifying how,
why and for whom interventions work are impor-
tant considerations for understanding intervention
effectiveness. [30]. However, the majority of stud-
ies did not specify a theoretical basis and findings
relevant to moderators and mediators were limited.
Moderate evidence suggests that greater benefits to
psychological well-being were gained by individu-
als with ambivalence over emotional expression [32].
Additionally, limited evidence suggests that greater
benefits to HRQoL were gained by men, individu-
als with lower levels of education, and those with
poor self-efficacy [39]. At the intervention level, no
component emerged as consistently associated with
gains in quality of life or well-being. It is, therefore,
not possible to conclude whether particular charac-
teristics of participants and/or interventions are most
likely to result in beneficial effects from psychosocial
interventions.
Implications for research
Whilst still at an early stage, research in this field
has developed rapidly in recent years, with all three
randomised controlled trials published in the last two
years. Although these developments are promising,
methodological limitations are still endemic in the
available literature. It is vital that research proceeds
with a strong emphasis on study quality such that
meaningful conclusions can be made. As the gold
standard for intervention research, randomised con-
trolled trials should be prioritised, with double-blind
designs and multi-site recruitment employed where
possible. Active controls should also be utilised to
establish whether beneficial effects are due to the
specific intervention or simply from non-specific
effects associated with being part of an interven-
tion. Caution should be exercised in the design
of active controls however, since equivalent non-
effective comparison interventions are challenging to
develop in psychosocial research [48]. In developing
interventions, researchers should ensure detailed pro-
tocols are utilised and treatment fidelity is assessed.
Given the degenerative nature of neuromuscular
diseases [24], it is vital that long term outcomes
of interventions are assessed. Additionally, to avoid
compounding current confusion, researchers should
clearly define outcomes of interest according to
accepted understandings of quality of life and well-
being. Validated, condition-specific measures of
quality of life may be preferable to generalised mea-
sures [48]. Moreover, since HRQoL is currently the
most frequently assessed outcome, greater emphasis
on global quality of life and well-being would be use-
ful to progress understanding of the potential impact
of interventions in this patient population.
The design and evaluation of psychosocial inter-
ventions should be informed by relevant theory. Thus,
future research could usefully include analysis of
moderator and mediator variables to develop new and
existing theoretical models, from which interventions
could then be developed. For example, researchers
could investigate which individuals are most likely to
benefit from an intervention by assessing the impact
of individual difference and demographic factors
on outcomes. Additionally, researchers could assess
the relative importance of potential mechanisms of
change, such as acceptance and altered cognitions.
Implications for clinical practice and policy
There is currently insufficient evidence to con-
clusively recommend psychosocial interventions for
adults with neuromuscular disorders. However, since
no study reported adverse outcomes from inter-
vention, it can be concluded that clinicians and
researchers should proceed in the development and
evaluation of appropriately designed psychosocial
interventions. Whilst one of the three moderate qual-
ity studies reported no beneficial effect of CBT, it
should be noted that this intervention focused only on
management of fatigue, which the authors acknowl-
edged was not an important goal for all participants
[34]. Given the individual variation and broad impact
of neuromuscular disorders in adulthood [24], it
is imperative that psychosocial interventions are
designed and delivered in a way that is patient-
centred.
Strengths and weaknesses of this review
This review extends findings from the one pre-
vious review in this area [22] to synthesise current
knowledge on the impact of psychosocial interven-
tions on quality of life and well-being in adults with
neuromuscular disorders. The broad and systematic
search strategy is a particular strength of this review.
The high proportion of irrelevant articles retrieved
from the full search indicates the search strategy had
low specificity. However, there is always a trade-off
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between sensitivity and specificity, with the potential
for missing important studies when specificity is high
[49]. Moreover, the results are in keeping with the
previous similar review in which a small number of
studies were included from a broad search [22]. The
main limitation of the current review is the hetero-
geneity amongst included studies. Due to the various
included study designs and outcomes measures, a
meta-analysis could not be performed. Consequently,
no statistical inferences regarding effectiveness can
be made.
CONCLUSION
There is currently no strong evidence to determine
whether psychosocial interventions improve quality
of life and well-being in adults with neuromuscu-
lar disorders. Although some benefits to both quality
of life and well-being have been identified from a
number of psychosocial interventions, such bene-
fits are almost exclusively short-term and subject to
bias. The paucity of high quality research and con-
fusion surrounding measurement of quality of life
and well-being impede meaningful interpretation of
findings. Further research with a strong emphasis on
study quality, clearly defined outcomes and consid-
eration of moderator variables is urgently required
to progress current understanding and inform rec-
ommendations for practice. Given that the overall
prevalence of neuromuscular disorders in adulthood
is increasing [50], it is vital that the identification
of effective, patient-centred interventions becomes a
prominent research priority.
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